SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-21-003412
Filing Date
2021-02-11
Accepted
2021-02-11 17:59:25
Documents
1
Period of Report
2021-02-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1525
  Complete submission text file 0001493152-21-003412.txt   2972
Mailing Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 856-848-8698
Akers Biosciences, Inc. (Issuer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 1375 KINGS HIGHWAY EAST FAIRFIELD CT 06824
Business Address
RHODES IAN (Reporting) CIK: 0001612365 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36268 | Film No.: 21621362